Jubilant Pharmova Limited (NSE: JUBLPHARMA) was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in November 2020. The company was founded in 1978 and is headquartered in Noida, India. It has a presence in over 100 countries worldwide and operates through several subsidiaries such as Jubilant Generics, Jubilant HollisterStier, Jubilant Radiopharma, and Jubilant Pharma.
For the quarter ended December 31, 2022, Jubilant Pharmova reported a consolidated Revenue of ₹1533.22 crore, which represents an increase of 18% YoY. The company’s Radipharma segment for the quarter stood at ₹613.21 crore, up 20% YoY, meanwhile the Net loss after tax was ₹16.04 crore. The Sterile Injectibles segment reported a revenue of ₹295.32 crore, which remained same YoY. The Contract Manufacturing of Sterile Injectables segment reported a revenue of ₹300.57 crore, up 13.6% YoY.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,